Speeding up early drug development
Drug aliquots for R&D
Therapeutic molecules of clinical-grade quality. From 1 mg. Ready to ship.
Therapeutic Molecules Biologics ADCs Monoclonal antibodies Bispecific antibodies Reference products
aliquoted from medicines
-
Which molecule(s)
are you looking for?
best selling products

Enfortumab Vedotin
3PA0052

Aldesleukin
M003286

Gemtuzumab ozogamicin
GL8910

Avalglucosidase alfa
CW3924

Alglucosidase alfa
DW1451

Emicizumab
B4164B18

Brentuximab Vedotin
12402887

Trastuzumab deruxtecan
387084

Risankizumab
1177826

Ocrelizumab
H0070H02
- Therapeutic drugs as aliquots
- Multiple drug batches
- Consumable, so no license needed
- Prompt Delivery
- Fraction of the original drug price
Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecules
Isotypes
Expiry Date
CoA
Filters
Sort results
Reset
Apply
ProductBatch | Antigen | Molecular Class | Drug Brand | Quantity per vial | Expiry Date | Price | |
---|---|---|---|---|---|---|---|
TNF alpha |
Biosimilar , Monoclonal Antibody |
Amgevita® |
2 mg |
12/2021 |
265,50 € |
Max: 10
Min: 1
Step: 1
|
|
TNF alpha |
Monoclonal Antibody |
Humira® |
4 mg |
11/2023 |
438,00 € |
Max: 10
Min: 1
Step: 1
|
|
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hulio® |
2 mg |
02/2023 |
265,50 € |
Max: 10
Min: 1
Step: 1
|
|
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hukyndra® |
2 mg |
10/2023 |
344,00 € |
Max: 10
Min: 1
Step: 1
|
|
TNF alpha |
Monoclonal Antibody |
Humira® |
4 mg |
03/2023 |
394,20 € |
Max:
Min: 1
Step: 1
|
|
TNF alpha |
Biosimilar , Monoclonal Antibody |
Yuflyma® |
4 mg |
02/2024 |
344,00 € |
Max: 10
Min: 1
Step: 1
|
|
TNF alpha |
Monoclonal Antibody |
Humira® |
4 mg |
09/2018 |
394,20 € |
Max: 5
Min: 1
Step: 1
|
|
TNF alpha |
Monoclonal Antibody |
Humira® |
4 mg |
12/2018 |
394,20 € |
Max: 10
Min: 1
Step: 1
|
|
TNF alpha |
Monoclonal Antibody |
Humira® |
4 mg |
03/2019 |
394,20 € |
Max: 10
Min: 1
Step: 1
|
|
TNF alpha |
Monoclonal Antibody |
Humira® |
4 mg |
03/2019 |
394,20 € |
Max: 10
Min: 1
Step: 1
|
Evidentic – fast, accurate, secure
Our products are empowering researchers worldwide

"After having great difficulty sourcing therapeutic antibodies in the small quantities required for research purposes, Evidentic has been a revelation! I have found them to be very friendly and prompt in replying to orders and queries. The online catalogue is very convenient and makes the ordering process easy and rapid. Having the products pre-reconstituted and aliquoted in a GMP Laboratory is also extremely helpful. In terms of service, delivery times and communication I rate them very highly."
Dr. Cassey McRae
Senior R&D Scientist at Avacta Life Sciences

"Evidentic gives rapid access to originator biologics and different batches. For biosimilar developers and regulators, it will shorten the time to gauge the analytical acceptance range for multiple CQAs of biotherapeutics."
Prof. Dr. Henning von Horsten
Life Science Engineering, HTW Berlin

“Evidentic was the only source that offered small aliquots of original therapeutic mAbs at an affordable price range. The aliquots came in an easy-to-use-and-store format that was apt for my research purpose.”
Ivanna Hrynchak
PhD Student ICNAS, Universidade de Coimbra

“We develop innovative and biosimilar mAbs for a global market. Evidentic’s aRMPs are a great source of cost-efficient reference products for our research and development program.”
Tom H. Jin, M.D.
Director of Process Development

"Evidentic is a new source of cost-efficient therapeutic mAbs for our immonassays. And easy to order!”
Thibault Jonckheere
CEO

"Evidentic drug aliquots have helped us speed up our antibody characterization assays and selection of clonal cell lines. An easy and reliable source!"
Prof. (emeritus) Dr. Florian Wurm
CSO & Founder

”Evidentic can supply different batches of reference products for pre-clinical research. The quick access to the in-stock batches allows for ad-hoc ordering, keeps costs down and makes a headstart possible!”
Anjan Selz
Vice President Head of Biosimilars EMEA

“Evidentic drug aliquots have significantly reduced our development cycle time and strengthened our ability to do detailed [protein] characterization”
Dr Stephan Schultz
Team Leader of Analytics/DSP
Why buy aliquots?

Evidentic is a young innovative company providing original drugs for research and new drug development.
Through our unique concept, we enable our customers to buy small quantities of these drugs as consumables, saving costs and time.